Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,783 | 613 | 98.6% |
| Education | $162.12 | 5 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,002 | 199 | $0 (2024) |
| Janssen Biotech, Inc. | $1,254 | 59 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,250 | 70 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $886.26 | 60 | $0 (2024) |
| PFIZER INC. | $653.27 | 45 | $0 (2024) |
| Merck Sharp & Dohme LLC | $327.51 | 15 | $0 (2024) |
| Gilead Sciences, Inc. | $321.82 | 14 | $0 (2024) |
| QOL Medical, LLC | $314.62 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $298.92 | 10 | $0 (2024) |
| Celgene Corporation | $280.61 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,033 | 96 | ABBVIE INC. ($606.85) |
| 2023 | $2,895 | 127 | ABBVIE INC. ($1,049) |
| 2022 | $1,879 | 103 | ABBVIE INC. ($608.95) |
| 2021 | $1,979 | 115 | AbbVie Inc. ($549.09) |
| 2020 | $447.32 | 28 | AbbVie Inc. ($148.03) |
| 2019 | $1,106 | 64 | AbbVie, Inc. ($477.93) |
| 2018 | $1,086 | 54 | AbbVie, Inc. ($433.54) |
| 2017 | $519.41 | 31 | AbbVie, Inc. ($128.25) |
All Payment Transactions
618 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $23.81 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $38.60 | General |
| Category: LIVER DISEASE | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Gastroenterology | ||||||
| 11/01/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Rare Disease | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: LIVER DISEASE | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Gastroenterology | ||||||
| 10/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.33 | General |
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Immunology | ||||||
| 09/11/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $19.54 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 619 | 779 | $257,290 | $77,484 |
| 2022 | 10 | 623 | 746 | $250,273 | $72,781 |
| 2021 | 11 | 648 | 845 | $269,535 | $77,369 |
| 2020 | 9 | 624 | 858 | $216,576 | $61,297 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 211 | 365 | $60,590 | $32,304 | 53.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 53 | 53 | $41,658 | $10,745 | 25.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 88 | 88 | $61,072 | $9,608 | 15.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $13,776 | $6,573 | 47.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 91 | 93 | $45,105 | $6,476 | 14.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 20 | 20 | $12,600 | $3,554 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 55 | $6,435 | $3,360 | 52.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $5,344 | $2,518 | 47.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $10,710 | $2,346 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 198 | 312 | $51,792 | $28,610 | 55.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 91 | 91 | $63,154 | $11,183 | 17.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 98 | 99 | $48,015 | $6,169 | 12.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $13,530 | $5,695 | 42.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 29 | 29 | $18,270 | $5,095 | 27.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 27 | 27 | $21,222 | $4,979 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 64 | $7,488 | $3,674 | 49.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $12,600 | $2,712 | 21.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $6,012 | $2,338 | 38.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 13 | $8,190 | $2,326 | 28.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 149 | 282 | $46,812 | $26,815 | 57.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 102 | 103 | $71,482 | $10,941 | 15.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 49 | 50 | $39,300 | $9,993 | 25.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 96 | 96 | $46,560 | $6,388 | 13.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 83 | $9,711 | $4,962 | 51.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $10,824 | $4,795 | 44.3% |
About Dr. Theodore Koh, MD
Dr. Theodore Koh, MD is a Gastroenterology healthcare provider based in Camillus, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114931037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Theodore Koh, MD has received a total of $11,945 in payments from pharmaceutical and medical device companies, with $2,033 received in 2024. These payments were reported across 618 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($11,783).
As a Medicare-enrolled provider, Koh has provided services to 2,514 Medicare beneficiaries, totaling 3,228 services with total Medicare billing of $288,931. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Camillus, NY
- Active Since 07/28/2006
- Last Updated 06/17/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1114931037
Products in Payments
- STELARA (Biological) $1,016
- RINVOQ (Biological) $1,016
- ENTYVIO (Biological) $841.57
- XIFAXAN (Drug) $806.96
- SKYRIZI (Biological) $678.60
- XELJANZ (Drug) $635.67
- Humira (Biological) $589.09
- HUMIRA (Biological) $573.63
- DUPIXENT (Biological) $401.33
- ZEPOSIA (Drug) $384.93
- LINZESS (Drug) $370.80
- Entyvio (Biological) $208.73
- SUCRAID (Drug) $205.52
- OCALIVA (Drug) $193.00
- MAVYRET (Drug) $179.48
- BRIDION (Drug) $169.68
- Creon (Drug) $144.06
- REMICADE (Biological) $130.20
- IBSRELA (Drug) $120.75
- CREON (Drug) $120.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Camillus
Dr. John Sun, Do, DO
Gastroenterology — Payments: $18,336
Scott Edison, Md, MD
Gastroenterology — Payments: $18,054
Dr. Thomas Lee, Md, MD
Gastroenterology — Payments: $17,318
Christine Granato, M.d, M.D
Gastroenterology — Payments: $7,714
Margaret Spinosa, Md, MD
Gastroenterology — Payments: $3,176
James Tifft, Md, MD
Gastroenterology — Payments: $962.77